Thursday, 31 December 2009

Moxaclav




Moxaclav may be available in the countries listed below.


Ingredient matches for Moxaclav



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Moxaclav in the following countries:


  • Bangladesh

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Moxaclav in the following countries:


  • Bangladesh

International Drug Name Search

Wednesday, 23 December 2009

Gayabeksin




Gayabeksin may be available in the countries listed below.


Ingredient matches for Gayabeksin



Sulfogaiacol

Sulfogaiacol is reported as an ingredient of Gayabeksin in the following countries:


  • Turkey

International Drug Name Search

Tuesday, 15 December 2009

Cohistan




Cohistan may be available in the countries listed below.


Ingredient matches for Cohistan



Chlorphenamine

Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Cohistan in the following countries:


  • Indonesia

International Drug Name Search

Sunday, 13 December 2009

Angitil




Angitil may be available in the countries listed below.


UK matches:

  • Angitil SR/XL 90,120,180,240 and 300 mg Prolonged Release Capsules (SPC)

Ingredient matches for Angitil



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Angitil in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Theo-Dur




In the US, Theo-Dur (theophylline systemic) is a member of the drug class methylxanthines and is used to treat Apnea of Prematurity, Asthma - acute and Asthma - Maintenance.

US matches:

  • Theo-Dur

Ingredient matches for Theo-Dur



Theophylline

Theophylline is reported as an ingredient of Theo-Dur in the following countries:


  • Denmark

  • Greece

  • Iceland

  • Italy

  • Norway

  • Spain

  • Sweden

International Drug Name Search

Wednesday, 9 December 2009

T-Cef




T-Cef may be available in the countries listed below.


Ingredient matches for T-Cef



Cefixime

Cefixime is reported as an ingredient of T-Cef in the following countries:


  • Bangladesh

International Drug Name Search

Wednesday, 2 December 2009

Quinine Bisulphate




Quinine Bisulphate may be available in the countries listed below.


UK matches:

  • Quinine Bisulphate Tablets 300mg (SPC)

Ingredient matches for Quinine Bisulphate



Quinine

Quinine Bisulphate (BANM) is known as Quinine in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 1 December 2009

Aciclovir EG




Aciclovir EG may be available in the countries listed below.


Ingredient matches for Aciclovir EG



Acyclovir

Aciclovir is reported as an ingredient of Aciclovir EG in the following countries:


  • Belgium

  • France

  • Italy

  • Luxembourg

International Drug Name Search

Monday, 30 November 2009

Neulactil




Neulactil may be available in the countries listed below.


UK matches:

  • Neulactil Forte Syrup
  • Neulactil Tablets
  • Neulactil Tablets (Winthrop Pharmaceuticals UK Ltd) (SPC)

Ingredient matches for Neulactil



Periciazine

Periciazine is reported as an ingredient of Neulactil in the following countries:


  • Australia

  • Denmark

  • Finland

  • Hong Kong

  • New Zealand

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 21 November 2009

Giardiasis Medications


Definition of Giardiasis: An infection of the small intestine caused by a protozoa,

Drugs associated with Giardiasis

The following drugs and medications are in some way related to, or used in the treatment of Giardiasis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Giardiasis





Drug List:

Sunday, 15 November 2009

Mirtazapin-1A Pharma




Mirtazapin-1A Pharma may be available in the countries listed below.


Ingredient matches for Mirtazapin-1A Pharma



Mirtazapine

Mirtazapine is reported as an ingredient of Mirtazapin-1A Pharma in the following countries:


  • Germany

International Drug Name Search

Saturday, 14 November 2009

Proctitis Medications


Definition of Proctitis: An inflammation of the rectum causing discomfort, bleeding, and occasionally, a discharge of mucus or pus.

Drugs associated with Proctitis

The following drugs and medications are in some way related to, or used in the treatment of Proctitis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Proctitis





Drug List:

Monday, 9 November 2009

Propyl-Thyracil




Propyl-Thyracil may be available in the countries listed below.


Ingredient matches for Propyl-Thyracil



Propylthiouracil

Propylthiouracil is reported as an ingredient of Propyl-Thyracil in the following countries:


  • Canada

International Drug Name Search

Sunday, 8 November 2009

Hoesmin




Hoesmin may be available in the countries listed below.


Ingredient matches for Hoesmin



Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Hoesmin in the following countries:


  • Japan

International Drug Name Search

Tuesday, 3 November 2009

Indapress




Indapress may be available in the countries listed below.


Ingredient matches for Indapress



Indapamide

Indapamide is reported as an ingredient of Indapress in the following countries:


  • Chile

International Drug Name Search

Sunday, 1 November 2009

Dropia




Dropia may be available in the countries listed below.


Ingredient matches for Dropia



Pioglitazone

Pioglitazone hydrochloride (a derivative of Pioglitazone) is reported as an ingredient of Dropia in the following countries:


  • Turkey

International Drug Name Search

Sunday, 25 October 2009

Lansoprazol Orifarm




Lansoprazol Orifarm may be available in the countries listed below.


Ingredient matches for Lansoprazol Orifarm



Lansoprazole

Lansoprazole is reported as an ingredient of Lansoprazol Orifarm in the following countries:


  • Denmark

International Drug Name Search

Saturday, 24 October 2009

Reese's Pinworm Medicine


Pronunciation: pi-RAN-tel
Generic Name: Pyrantel Pamoate
Brand Name: Reese's Pinworm Medicine


Reese's Pinworm Medicine is used for:

Treating certain worm infections (eg, pinworm, roundworm).


Reese's Pinworm Medicine is an anthelmintic agent. It works by paralyzing the nervous system of intestinal parasites (worms). The parasite is then passed in the stool.


Do NOT use Reese's Pinworm Medicine if:


  • you are allergic to any ingredient in Reese's Pinworm Medicine

  • you have liver problems

Contact your doctor or health care provider right away if any of these apply to you.



Before using Reese's Pinworm Medicine:


Some medical conditions may interact with Reese's Pinworm Medicine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have worms other than pinworms

  • if others in your home also have pinworms

Some MEDICINES MAY INTERACT with Reese's Pinworm Medicine. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Piperazine because the effectiveness of Reese's Pinworm Medicine may be decreased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Reese's Pinworm Medicine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Reese's Pinworm Medicine:


Use Reese's Pinworm Medicine as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Reese's Pinworm Medicine may be taken on an empty stomach or with food, milk, or juice.

  • Wear tight underwear both day and night while taking Reese's Pinworm Medicine.

  • Reese's Pinworm Medicine is usually prescribed as a single dose.

  • Only one dose of Reese's Pinworm Medicine is required. If you forget to take Reese's Pinworm Medicine, take it as soon as you remember.

Ask your health care provider any questions you may have about how to use Reese's Pinworm Medicine.



Important safety information:


  • Reese's Pinworm Medicine may cause drowsiness or dizziness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Reese's Pinworm Medicine. Using Reese's Pinworm Medicine alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.

  • This infection spreads easily to family members and close contacts. To prevent reinfection: Disinfect toilet and change and wash underwear, bed linens, towels, clothes, and pajamas daily. Wash hands with soap often during the day, especially before eating and after using the toilet. Do not scratch the infected area or place your fingers in your mouth.

  • The entire household should be treated with Reese's Pinworm Medicine if one individual in the household has pinworms.

  • After treatment with Reese's Pinworm Medicine, clean the bedroom floor by vacuuming or damp mopping.

  • If any worms other than pinworms are visible after treatment with Reese's Pinworm Medicine, contact your doctor.

  • Use Reese's Pinworm Medicine with extreme caution in CHILDREN younger than 2 years of age. Safety and effectiveness in this age group have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Reese's Pinworm Medicine, discuss with your doctor the benefits and risks of using Reese's Pinworm Medicine during pregnancy. It is unknown if Reese's Pinworm Medicine is excreted in breast milk. If you are or will be breast-feeding while you are using Reese's Pinworm Medicine, check with your doctor or pharmacist to discuss the risks to your baby.


Possible side effects of Reese's Pinworm Medicine:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea; dizziness; drowsiness; headache; loss of appetite; nausea; stomach cramps; trouble sleeping; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Reese's Pinworm Medicine side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Reese's Pinworm Medicine:

Store Reese's Pinworm Medicine at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Reese's Pinworm Medicine out of the reach of children and away from pets.


General information:


  • If you have any questions about Reese's Pinworm Medicine, please talk with your doctor, pharmacist, or other health care provider.

  • Reese's Pinworm Medicine is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Reese's Pinworm Medicine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Reese's Pinworm Medicine resources


  • Reese's Pinworm Medicine Side Effects (in more detail)
  • Reese's Pinworm Medicine Use in Pregnancy & Breastfeeding
  • Reese's Pinworm Medicine Drug Interactions
  • Reese's Pinworm Medicine Support Group
  • 0 Reviews for Reese's Pinworm Medicine - Add your own review/rating


Compare Reese's Pinworm Medicine with other medications


  • Ascariasis
  • Enterobiasis
  • Hookworm Infection, Necator or Ancylostoma
  • Moniliformis Infection
  • Pinworm Infection, Enterobius vermicularis
  • Trichostrongylosis

Tuesday, 20 October 2009

Dimethyl Sulfoxide


Pronunciation: dye-METH-il sul-FOX-ide
Generic Name: Dimethyl Sulfoxide
Brand Name: Generic only. No brands available.


Dimethyl Sulfoxide is used for:

Treating symptoms associated with a certain bladder problem (interstitial cystitis). It may also be used for other conditions as determined by your doctor.


Dimethyl Sulfoxide is a sterile solution of dimethyl sulfoxide. It is unknown exactly how Dimethyl Sulfoxide works.


Do NOT use Dimethyl Sulfoxide if:


  • you are allergic to any ingredient in Dimethyl Sulfoxide

Contact your doctor or health care provider right away if any of these apply to you.



Before using Dimethyl Sulfoxide:


Some medical conditions may interact with Dimethyl Sulfoxide. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have cancer of the bladder or urinary tract

Some MEDICINES MAY INTERACT with Dimethyl Sulfoxide. However, no specific interactions with Dimethyl Sulfoxide are known at this time.


This may not be a complete list of all interactions that may occur. Ask your health care provider if Dimethyl Sulfoxide may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Dimethyl Sulfoxide:


Use Dimethyl Sulfoxide as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Dimethyl Sulfoxide is usually administered at your doctor's office, hospital, or clinic. If you are using Dimethyl Sulfoxide at home, carefully follow the procedures taught to you by your health care provider.

  • If you have severe symptoms or an especially sensitive bladder, the first few treatments may be performed while you are under anesthesia.

  • Dimethyl Sulfoxide is placed into the bladder by catheter or special syringe. An analgesic gel may be applied prior to insertion of the catheter to help prevent spasms and discomfort.

  • This treatment may be repeated every 2 weeks until relief of symptoms occurs, unless prescribed differently by your doctor. After you experience relief, the treatment may be repeated less often as determined by your doctor.

  • It may take several weeks for the full benefit of Dimethyl Sulfoxide to be seen. Do not stop using Dimethyl Sulfoxide without talking with your doctor.

  • If you miss a dose of Dimethyl Sulfoxide, contact your doctor immediately.

Ask your health care provider any questions you may have about how to use Dimethyl Sulfoxide.



Important safety information:


  • A garlic-like taste may appear a few minutes after use. This taste may last several hours. Garlic odor on the skin or breath may last up to 72 hours.

  • The discomfort associated with treatment usually lessens with additional treatments.

  • Dimethyl Sulfoxide may be harmful if swallowed. If you may have taken Dimethyl Sulfoxide by mouth, contact your local poison control center or emergency room immediately.

  • LAB TESTS, including eye exams, liver function tests, kidney function tests, and complete blood counts, may be performed to monitor your progress or to check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Dimethyl Sulfoxide with extreme caution in CHILDREN. Safety and effectiveness have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant while taking Dimethyl Sulfoxide, discuss with your doctor the benefits and risks of using Dimethyl Sulfoxide during pregnancy. It is unknown if Dimethyl Sulfoxide is excreted in breast milk. If you are or will be breast-feeding while you are using Dimethyl Sulfoxide, check with your doctor or pharmacist to discuss the risks to your baby.


Possible side effects of Dimethyl Sulfoxide:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Bladder discomfort; garlic odor on breath or skin for up to 72 hours; garlic taste for several hours.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); eye pain or burning; vision changes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Dimethyl Sulfoxide side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Dimethyl Sulfoxide:

Store Dimethyl Sulfoxide at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Protect from light. Do not store in the bathroom. Keep Dimethyl Sulfoxide out of the reach of children and away from pets.


General information:


  • If you have any questions about Dimethyl Sulfoxide, please talk with your doctor, pharmacist, or other health care provider.

  • Dimethyl Sulfoxide is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dimethyl Sulfoxide. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dimethyl Sulfoxide resources


  • Dimethyl Sulfoxide Side Effects (in more detail)
  • Dimethyl Sulfoxide Use in Pregnancy & Breastfeeding
  • Dimethyl Sulfoxide Drug Interactions
  • Dimethyl Sulfoxide Support Group
  • 0 Reviews for Dimethyl Sulfoxide - Add your own review/rating


  • dimethyl sulfoxide Intravesical Advanced Consumer (Micromedex) - Includes Dosage Information

  • dimethyl sulfoxide Concise Consumer Information (Cerner Multum)

  • Rimso-50 Prescribing Information (FDA)



Compare Dimethyl Sulfoxide with other medications


  • Interstitial Cystitis

Thursday, 15 October 2009

Clarus




Clarus may be available in the countries listed below.


Ingredient matches for Clarus



Isotretinoin

Isotretinoin is reported as an ingredient of Clarus in the following countries:


  • Canada

International Drug Name Search

Wednesday, 14 October 2009

Ridinox




Ridinox may be available in the countries listed below.


Ingredient matches for Ridinox



Idoxuridine

Idoxuridine is reported as an ingredient of Ridinox in the following countries:


  • India

International Drug Name Search

Monday, 12 October 2009

Riboflavin


Class: Vitamin B Complex
ATC Class: A11HA04
VA Class: VT106
CAS Number: 83-88-5

Introduction

Water-soluble, B complex vitamin.a b


Uses for Riboflavin


Riboflavin Deficiency


Used to prevent and treat riboflavin deficiency (ariboflavinosis).a b


Riboflavin deficiency may occur in patients with long-standing infections, liver disease, alcoholism, malignancy, cardiac disease, diabetes mellitus, and those taking probenecid.a


Dietary Requirements


Adequate intake needed to prevent riboflavin deficiency (ariboflavinosis).101 b


Adequate intake of riboflavin usually can be accomplished through consumption of foodstuffs, including milk, bread products, and fortified cereals.101 b


Estimated Average Requirement (EAR) and Recommended Dietary Allowance (RDA) in adults based on a combination of criteria including erythrocyte glutathione reductase activity and urinary excretion of riboflavin.101 b


Adequate intake (AI) established for infants ≤6 months of age based on riboflavin intake of infants fed principally human milk;b AI for infants 7–12 months of age based on the AI for younger infants and data from adults.b


EAR and RDA for children 1–18 years of age based on data in adults.101 b


Urinalysis Marker


Used as a urine marker when mixed with various drugs to test for patient compliance with the therapeutic regimen of these drugs.a


Migraine Headaches


Has been used for prophylaxis of migraine headache to decrease the frequency and duration of attacks.102


Riboflavin Dosage and Administration


General



  • Correct poor dietary habits and consider a multivitamin preparation containing riboflavin in patients with vitamin deficiencies since poor dietary habits often result in concurrent deficiencies.a



Administration


Administer orally.a e


May be given by IM injection or IV infusion as a component of a multivitamin injection.a A parenteral formulation containing riboflavin alone is not currently commercially available.a


Oral Administration


Administer orally, preferably with food.e


Dosage


Pediatric Patients


Riboflavin Deficiency (Ariboflavinosis)

Oral

Usually, 3–10 mg daily.a


Dietary and Replacement Requirements

Oral

Infants <6 months of age: AI is 0.3 mg (0.04 mg/kg) daily.101


Infants 6–12 months of age: AI is 0.4 mg (0.04 mg/kg) daily.101


Children 1–3 years of age: RDA is 0.5 mg daily.101


Children 4–8 years of age: RDA is 0.6 mg daily.101


Children 9–13 years of age: RDA is 0.9 mg daily.101


Girls 14–19 years of age: RDA is 1 mg daily.101


Boys 14–19 years of age: RDA is 1.3 mg daily.101


Adults


Riboflavin Deficiency (Ariboflavinosis)

Oral

Usually, 5–30 mg daily given in divided doses.a


Patients with normocytic, normochromic anemia: 10 mg daily usually increases reticulocyte count within a few days.a


Dietary and Replacement Requirements

Oral

Women ≥19 years of age: RDA is 1.1 mg daily.101


Men ≥19 years of age: RDA is 1.3 mg daily.101


These RDAs will not meet the needs of individuals with severe malabsorption.101 b


Migraine Headaches

Oral

400 mg daily; maximal benefit may occur after 3 months of prophylaxis therapy.102


Special Populations


Pregnant women: RDA is 1.4 mg daily.101 Riboflavin intake exceeding this RDA may be needed by women who are pregnant with more than one fetus.101 b


Lactating women: RDA is 1.6 mg daily.101 Riboflavin intake exceeding this RDA may be needed by mothers nursing more than one infant.101 b


May require additional riboflavin intake in patients who are extremely physically active.b


Renal Impairment


Patients undergoing hemodialysis or peritoneal dialysis may require additional riboflavin.b


Cautions for Riboflavin


Contraindications



  • Known hypersensitivity to riboflavin or any ingredient in the formulation.c



Warnings/Precautions


Warnings


Concomitant Diseases

Increased riboflavin deficiency risk in patients with cancer, cardiac disease, or diabetes mellitus.b


General Precautions


Fixed-Combination Preparations

Consider the cautions, precautions, and contraindications associated with other drug(s) and vitamins in fixed-combination preparations.c


Specific Populations


Pregnancy

Category A.d Category C (for dosages >RDA).d (See Special Populations under Dosage and Administration.)


Lactation

Distributed into human milk.101 a d


Common Adverse Effects


Usually nontoxic even in large doses.a b


Interactions for Riboflavin


Specific Drugs and Laboratory Tests






























Drug or Test



Interaction



Comments



Aminoglyosides (kanamycin, streptomycin)



Possible decreased antibiotic activity c



Bleomycin



Inactivated in vitro by riboflavinc



Erythromycin



Possible decreased antibiotic activity c



Probenecid



Decreased absorption of riboflavina



Propantheline



Propantheline may delay the rate of riboflavin absorption, but increase the total amount absorbed a



Spectrometry or color reaction urinalysis



Possible color interferencea



Tests for catecholamines



Possible false elevations in fluorometric determinations of plasma or urinary catecholaminesa



Tests for urobilinogen



Possible false elevations in fluorometric determinations of plasma or urinary urobilinogena


Riboflavin Pharmacokinetics


Absorption


Bioavailability


Readily absorbed from the upper GI tract.a b Rate of absorption is proportional to intake.b


Onset


Therapeutic response in riboflavin-deficient patients may require several days for ocular and dermatologic manifestations of deficiency to improve.a


Following oral administration in deficient patients with normocytic, normochromic anemia, an increase in reticulocyte count usually occurs within a few days.a


Food


Food increases extent of absorption.a b


Special Populations


Extent of absorption is decreased in patients with hepatitis, cirrhosis, or biliary obstruction.a


Distribution


Extent


Widely distributed into most tissues, including GI mucosal cells, erythrocytes, and the liver as riboflavin 5-phosphate (flavin mononucleotide [FMN]) and flavin adenine dinucleotide (FAD).a b Free riboflavin is present in the retina.a


Stored in limited amounts in the liver, spleen, kidneys, and heart, mainly as FAD.a


Crosses the placenta and is distributed into milk.101


Plasma Protein Binding


About 60% as FAD and FMN.a


Elimination


Metabolism


Phosphorylated to FMN in GI mucosal cells, erythrocytes, and the liver; FMN is converted to FAD in the liver.a


Elimination Route


Urine (about 9%) as unchanged drug; fate of the remainder of the dose not determined.a


Half-life


Following oral or IM administration, about 66–84 minutes.a


Special Populations


Removal by hemodialysis is slower than normal renal excretion.a


In neonates, urinary excretion is slow; however, the cumulative amount excreted is similar to the amount excreted by older infants.b


Stability


Storage


Oral


Tablets

Tight, light-resistant containers at 15–30°C.a


Compatibility


For information on systemic interactions resulting from concomitant use, see Interactions.


Incompatible with alkaline solutions.a


ActionsActions



  • An exogenous source of riboflavin is required for tissue respiration.a




  • Converts to coenzymes (FMN and FAD) involved in oxidation-reduction reactions of organic substrates and in intermediary metabolism.a b e




  • Flavocoenzymes are involved in the formation of some vitamins and their coenzymes, including niacin, vitamin B6, and vitamin B12.101 b




  • Indirectly involved in maintaining erythrocyte integrity.a



Advice to Patients



  • Importance of proper dietary habits, including taking appropriate AI or RDA of vitamin B2.




  • Inform patients that large doses of riboflavin can result in bright yellow urine.a




  • Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.b




  • Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs.b




  • Importance of informing patients of other important precautionary information. (See Cautions.)



Preparations


Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.


Riboflavin, riboflavin 5-phosphate, and riboflavin 5-phosphate sodium are also commercially available in combination with other vitamins, minerals, amino acids, cerebral stimulants, protein supplements, infant formulas, enzymes, hormones, sedatives, laxatives, and unsaturated fatty acids.a For IM injection, riboflavin is commercially available in combination with other vitamins and iron.a For IV infusion, riboflavin is commercially available in combination with other vitamins.a c


* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name






































Riboflavin

Routes



Dosage Forms



Strengths



Brand Names



Manufacturer



Bulk



Powder*



Oral



Capsules



100 mg*



Tablets



25 mg*



50 mg*



100 mg*



Sublingual



Tablets



25 mg (as flavin mononucleotide [coenzymated])*



Riboflavin Sublingual Tablets



Disclaimer

This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.


The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care.

AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions August 01, 2009. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.


† Use is not currently included in the labeling approved by the US Food and Drug Administration.




References


Only references cited for selected revisions after 1984 are available electronically.



100. National Research Council Food and Nutrition Board Subcommittee on the Tenth Edition of the RDAs. Recommended dietary allowances. 10th ed. Washington, DC: National Academies Press; 1989:132-7.



101. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes of the Food and Nutrition Board, Institute of Medicine, National Academy of Sciences. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academies Press; 1998.



102. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial. Neurology. 1998; 50:466-70. [IDIS 401485] [PubMed 9484373]



a. AHFS Drug Information 2009. McEvoy GK, ed. Riboflavin. Bethesda, MD: American Society of Health-System Pharmacists; 2009.



b. Otten JJ, Hellwig JP, Meyers LD, eds. Dietary reference intakes: the essential guide to nutritional requirements. Washington, DC: National Academies Press; 2006.



c. Baxter. INFUVITE Adult (Multiple vitamins for Infusion) prescribing information. Deerfield, IL; 2004 May.



d. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 7th ed. Baltimore , MD: Williams & Wilkins; 2005:1410–11.



e. Nature’s Way. Vitamin B2 (riboflavin) capsules product information. Springville, UT; 2004.



More Riboflavin resources


  • Riboflavin Support Group
  • 3 Reviews for Riboflavin - Add your own review/rating


  • riboflavin Concise Consumer Information (Cerner Multum)

  • riboflavin Advanced Consumer (Micromedex) - Includes Dosage Information



Compare Riboflavin with other medications


  • Dietary Supplementation
  • Headache
  • Migraine Prevention
  • Vitamin/Mineral Supplementation and Deficiency

Sunday, 11 October 2009

Movipride




Movipride may be available in the countries listed below.


Ingredient matches for Movipride



Bromopride

Bromopride is reported as an ingredient of Movipride in the following countries:


  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

  • Panama

International Drug Name Search

Sunday, 4 October 2009

Theophyllin Lindopharm




Theophyllin Lindopharm may be available in the countries listed below.


Ingredient matches for Theophyllin Lindopharm



Theophylline

Theophylline is reported as an ingredient of Theophyllin Lindopharm in the following countries:


  • Germany

International Drug Name Search

Friday, 2 October 2009

Alprazolam Unilan




Alprazolam Unilan may be available in the countries listed below.


Ingredient matches for Alprazolam Unilan



Alprazolam

Alprazolam is reported as an ingredient of Alprazolam Unilan in the following countries:


  • Portugal

International Drug Name Search

Monday, 21 September 2009

Nimodipina EG




Nimodipina EG may be available in the countries listed below.


Ingredient matches for Nimodipina EG



Nimodipine

Nimodipine is reported as an ingredient of Nimodipina EG in the following countries:


  • Italy

International Drug Name Search

Sunday, 20 September 2009

Iosan




Iosan may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Iosan



Povidone Iodine

Povidone-Iodine is reported as an ingredient of Iosan in the following countries:


  • United Kingdom

International Drug Name Search

Monday, 14 September 2009

Meligran




Meligran may be available in the countries listed below.


Ingredient matches for Meligran



Buflomedil

Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Meligran in the following countries:


  • Greece

International Drug Name Search

Friday, 11 September 2009

Karbasif




Karbasif may be available in the countries listed below.


Ingredient matches for Karbasif



Carbamazepine

Carbamazepine is reported as an ingredient of Karbasif in the following countries:


  • Turkey

International Drug Name Search

Sulpigut




Sulpigut may be available in the countries listed below.


Ingredient matches for Sulpigut



Sulpiride

Sulpiride is reported as an ingredient of Sulpigut in the following countries:


  • Serbia

International Drug Name Search

Wednesday, 9 September 2009

Ostiseptil




Ostiseptil may be available in the countries listed below.


Ingredient matches for Ostiseptil



Urea

Urea is reported as an ingredient of Ostiseptil in the following countries:


  • Peru

International Drug Name Search

Tuesday, 8 September 2009

Tamox




Tamox may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Tamox



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Tamox in the following countries:


  • Austria

  • Germany

Tamoxifen

Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tamox in the following countries:


  • Brazil

  • Ireland

International Drug Name Search

Monday, 7 September 2009

Stavudine




In the US, Stavudine (stavudine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

  • Stavudine

  • Stavudine Solution

  • Stavudine Oral Solution

Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF04

CAS registry number (Chemical Abstracts Service)

0003056-17-5

Chemical Formula

C10-H12-N2-O4

Molecular Weight

224

Therapeutic Category

Antiviral agent, HIV reverse transcriptase inhibitor

Chemical Name

1-(2,3-Dideoxy-ß-D-glycero-pent-2-enofuranosyl)thymine

Foreign Names

  • Stavudinum (Latin)
  • Stavudin (German)
  • Stavudine (French)
  • Estavudina (Spanish)

Generic Names

  • Sanilvudine (OS: JAN)
  • Stavudine (OS: BAN, USAN)
  • BMY 27857 (IS: Bristol-Myers)
  • d4T (IS)
  • Stavudine (PH: BP 2010, Ph. Int. 4, USP 32, Ph. Eur. 6)
  • Stavudinum (PH: Ph. Eur. 6)

Brand Names

  • Actastav
    Actavis, Russian Federation


  • Aspen Stavudine
    Aspen Pharmacare, South Africa


  • Avostav
    Ranbaxy Laboratories, Ethiopia


  • Ciplastavir
    Biotoscana, Colombia


  • Coviro (Stavudine and Lamivudine)
    Ranbaxy, Myanmar


  • Emduo (Stavudine and Lamivudine)
    Emcure, Myanmar


  • Emtri (Stavudine and Lamivudine, + Nevirapine)
    Emcure, Myanmar


  • Estavudina
    Induquimica, Peru


  • Estavudox
    Biotoscana, Peru


  • Exvihr
    Biogen, Colombia; Biogen, Peru


  • Flamistav
    Flamingo Pharmacueticals, Ethiopia


  • Lamitec-S (Stavudine and Lamivudine)
    Zifam India, Myanmar


  • Landstav
    Landsteiner, Mexico


  • Lazid (Stavudine and Lamivudine)
    Emcure, Myanmar


  • Lion
    Filaxis, Argentina


  • Maxivir (Stavudine and Lamivudine, + Nevirapine)
    Okasa, Myanmar


  • Medilam (Stavudine and Lamivudine)
    Meditab, Myanmar


  • S.T.V.
    Ivax, Argentina


  • Sonke-LamiNevStav (Stavudine and Lamivudine, + Nevirapine)
    Ranbaxy, South Africa


  • Sonke-Stavudine
    Ranbaxy, South Africa


  • Stadine
    Emcure, Myanmar


  • Stamar
    LKM, Argentina


  • Stavex
    Aurobindo Pharma, Ethiopia


  • Stavir
    Cipla, Ethiopia; Cipla, Georgia; Cipla, India; Cipla Medpro, South Africa; Pharmaceutical, Venezuela


  • Stavubergen
    Paylos, Argentina


  • Stavudina Dosa
    Dosa, Argentina


  • Stavudine Stada
    Stada, Vietnam


  • Stavudine
    Aurobindo, United States; Cipla, United States; Hetero, United States; Mylan, United States


  • Tonavir
    Richmond, Argentina; Richmond, Peru


  • Triomune (Stavudine and Lamivudine, + Nevirapine)
    Cipla Medpro, South Africa


  • Virolans (Stavudine and Lamivudine, + Nevirapine)
    Ranbaxy, Myanmar


  • Virozen (Stavudine and Lamivudine, + Nevirapine)
    Zifam India, Myanmar


  • Zerit
    Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Bosnia & Herzegowina; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Burkina Faso; Bristol-Myers Squibb, Burundi; Bristol-Myers Squibb, Benin; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Congo; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Cote D'ivoire; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, Cameroon; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Algeria; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, Ethiopia; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Gabon; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Georgia; Bristol-Myers Squibb, Guinea; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Mali; Bristol-Myers Squibb, Mauritania; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Niger; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Serbia; Bristol-Myers Squibb, Russian Federation; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb, Senegal; Bristol-Myers Squibb, Chad; Bristol-Myers Squibb, Togo; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Tunisia; Bristol-Myers Squibb, Turkey; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Venezuela; Bristol-Myers Squibb, South Africa; Bristol-Myers Squibb, Zaire; PharmaSwiss, Croatia (Hrvatska)

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 6 September 2009

Tosuxacin




Tosuxacin may be available in the countries listed below.


Ingredient matches for Tosuxacin



Tosufloxacin

Tosufloxacin tosilate (a derivative of Tosufloxacin) is reported as an ingredient of Tosuxacin in the following countries:


  • Japan

International Drug Name Search

Friday, 4 September 2009

Tramadol HCl Actavis




Tramadol HCl Actavis may be available in the countries listed below.


Ingredient matches for Tramadol HCl Actavis



Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tramadol HCl Actavis in the following countries:


  • Netherlands

International Drug Name Search

Thursday, 3 September 2009

Colifoam




Colifoam may be available in the countries listed below.


UK matches:

  • Colifoam
  • Colifoam (SPC)

Ingredient matches for Colifoam



Hydrocortisone

Hydrocortisone is reported as an ingredient of Colifoam in the following countries:


  • New Zealand

Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Colifoam in the following countries:


  • Australia

  • Austria

  • Denmark

  • Finland

  • Germany

  • Greece

  • Iceland

  • Ireland

  • Italy

  • Luxembourg

  • Norway

  • Sweden

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 2 September 2009

RAN-Risperidone




RAN-Risperidone may be available in the countries listed below.


Ingredient matches for RAN-Risperidone



Risperidone

Risperidone is reported as an ingredient of RAN-Risperidone in the following countries:


  • Canada

International Drug Name Search

Monday, 31 August 2009

Deroxat




Deroxat may be available in the countries listed below.


Ingredient matches for Deroxat



Paroxetine

Paroxetine is reported as an ingredient of Deroxat in the following countries:


  • Tunisia

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Deroxat in the following countries:


  • France

  • Switzerland

International Drug Name Search

Wednesday, 26 August 2009

Topilex




Topilex may be available in the countries listed below.


Ingredient matches for Topilex



Topiramate

Topiramate is reported as an ingredient of Topilex in the following countries:


  • Bulgaria

  • Slovakia

International Drug Name Search

Magnesium-Diasporal 2mmol / 4mmol




Magnesium-Diasporal 2mmol/4mmol may be available in the countries listed below.


Ingredient matches for Magnesium-Diasporal 2mmol/4mmol



Magnesium Sulfate

Magnesium Sulfate heptahydrate (a derivative of Magnesium Sulfate) is reported as an ingredient of Magnesium-Diasporal 2mmol/4mmol in the following countries:


  • Germany

International Drug Name Search

Monday, 24 August 2009

Ranitidine Tablets



Pronunciation: ra-NI-ti-deen
Generic Name: Ranitidine
Brand Name: Zantac


Ranitidine is used for:

Treating heartburn or irritation of the esophagus caused by gastroesophageal reflux disease (GERD). It may be used to treat and maintain healing of severe irritation of the esophagus (erosive esophagitis). It may be used for short-term treatment of stomach or small intestinal ulcers. It may be used to maintain healing of stomach or small intestinal ulcers. It may be used to treat conditions that cause your body to make too much stomach acid (eg, Zollinger-Ellison syndrome). It may also be used for other conditions as determined by your doctor.


Ranitidine is an H2-receptor blocker. It works by blocking the action of histamine in the stomach. This reduces the amount of acid the stomach makes. Reducing stomach acid helps to reduce heartburn, heal irritation of the esophagus, and heal ulcers of the stomach or intestines.


Do NOT use Ranitidine if:


  • you are allergic to any ingredient in Ranitidine

  • you have a history of the blood disease porphyria

  • you are taking dasatinib

Contact your doctor or health care provider right away if any of these apply to you.



Before using Ranitidine:


Some medical conditions may interact with Ranitidine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of kidney or liver problems

Some MEDICINES MAY INTERACT with Ranitidine. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Certain benzodiazepines (eg, midazolam, triazolam), glipizide, procainamide, or warfarin because the risk of their side effects may be increased by Ranitidine

  • Dasatinib, delavirdine, gefitinib, certain HIV protease inhibitors (eg, atazanavir), itraconazole, or ketoconazole because their effectiveness may be decreased by Ranitidine

This may not be a complete list of all interactions that may occur. Ask your health care provider if Ranitidine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Ranitidine:


Use Ranitidine as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Ranitidine by mouth with or without food.

  • If you also take itraconazole or ketoconazole, ask your doctor or pharmacist how to take it with Ranitidine.

  • You may take antacids while you are using Ranitidine if you are directed to do so by your doctor.

  • Continue to take Ranitidine even if you feel well. Do not miss any doses.

  • If you miss a dose of Ranitidine, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Ranitidine.



Important safety information:


  • Ranitidine may rarely cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Ranitidine with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Ranitidine may interfere with certain lab tests, including urine protein tests. Be sure your doctor and lab personnel know you are taking Ranitidine.

  • Ranitidine should be used with extreme caution in CHILDREN younger than 1 month old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Ranitidine while you are pregnant. Ranitidine is found in breast milk. If you are or will be breast-feeding while you use Ranitidine, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Ranitidine:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; diarrhea; headache; nausea; stomach upset.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); change in the amount of urine produced; confusion; dark urine; depression; fast, slow, or irregular heartbeat; fever, chills, or sore throat; hallucinations; severe or persistent headache or stomach pain; unusual bruising or bleeding; yellowing of the eyes or skin.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include dizziness; trouble walking.


Proper storage of Ranitidine:

Store Ranitidine at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly closed container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Ranitidine out of the reach of children and away from pets.


General information:


  • If you have any questions about Ranitidine, please talk with your doctor, pharmacist, or other health care provider.

  • Ranitidine is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Ranitidine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Ranitidine resources


  • Ranitidine Use in Pregnancy & Breastfeeding
  • Drug Images
  • Ranitidine Drug Interactions
  • Ranitidine Support Group
  • 32 Reviews for Ranitidine - Add your own review/rating


Compare Ranitidine with other medications


  • Duodenal Ulcer
  • Duodenal Ulcer Prophylaxis
  • Erosive Esophagitis
  • Gastric Ulcer Maintenance Treatment
  • Gastrointestinal Hemorrhage
  • GERD
  • Indigestion
  • Pathological Hypersecretory Conditions
  • Stomach Ulcer
  • Stress Ulcer Prophylaxis
  • Surgical Prophylaxis
  • Zollinger-Ellison Syndrome

Sunday, 23 August 2009

Bicalutamide Medac




Bicalutamide Medac may be available in the countries listed below.


Ingredient matches for Bicalutamide Medac



Bicalutamide

Bicalutamide is reported as an ingredient of Bicalutamide Medac in the following countries:


  • Greece

International Drug Name Search

Saturday, 22 August 2009

Pamabrom




In the US, Pamabrom (pamabrom systemic) is a member of the drug class miscellaneous diuretics and is used to treat Abdominal Distension, Edema and Premenstrual Dysphoric Disorder.

US matches:

  • Pamabrom

Scheme

USAN

CAS registry number (Chemical Abstracts Service)

0000606-04-2

Chemical Formula

C11-H18-Br-N5-O3

Molecular Weight

348

Therapeutic Category

Diuretic agent

Chemical Name

1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-1,3-dimethyl-, compd. with 2-amino-2-methyl-1-propanol (1:1)

Foreign Name

  • 2-Amino-2-methylpropanol 8-bromtheophyllin (German)

Generic Names

  • Pamabrom (OS: USAN)
  • 8-Bromotheophylline comp. with 2-amino-2-methyl-1-propanol (IS)
  • Pamabrom (PH: USP 32)

Brand Name

  • Panadol Menstrual (Pamabrom and Paracetamol)
    GlaxoSmithKline, Singapore

International Drug Name Search

Glossary

ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 21 August 2009

Cefozim




Cefozim may be available in the countries listed below.


Ingredient matches for Cefozim



Ceftazidime

Ceftazidime is reported as an ingredient of Cefozim in the following countries:


  • Vietnam

International Drug Name Search

Thursday, 20 August 2009

Ranclic




Ranclic may be available in the countries listed below.


Ingredient matches for Ranclic



Pirenzepine

Pirenzepine dihydrochloride (a derivative of Pirenzepine) is reported as an ingredient of Ranclic in the following countries:


  • Japan

International Drug Name Search

Saturday, 15 August 2009

Tensiol




Tensiol may be available in the countries listed below.


Ingredient matches for Tensiol



Olmesartan

Olmesartan Medoxomil is reported as an ingredient of Tensiol in the following countries:


  • Slovenia

International Drug Name Search

Wednesday, 12 August 2009

Ceftazidime Panpharma




Ceftazidime Panpharma may be available in the countries listed below.


Ingredient matches for Ceftazidime Panpharma



Ceftazidime

Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Ceftazidime Panpharma in the following countries:


  • France

International Drug Name Search

Tuesday, 4 August 2009

Diart




Diart may be available in the countries listed below.


Ingredient matches for Diart



Azosemide

Azosemide is reported as an ingredient of Diart in the following countries:


  • Japan

International Drug Name Search

Saturday, 1 August 2009

Platinex




Platinex may be available in the countries listed below.


Ingredient matches for Platinex



Cisplatin

Cisplatin is reported as an ingredient of Platinex in the following countries:


  • Bahrain

  • Bosnia & Herzegowina

  • Croatia (Hrvatska)

  • Egypt

  • Iran

  • Iraq

  • Jordan

  • Kuwait

  • Lebanon

  • Myanmar

  • Oman

  • Qatar

  • Saudi Arabia

  • Serbia

  • Slovenia

  • Syria

  • Taiwan

  • United Arab Emirates

  • Yemen

International Drug Name Search

Monday, 27 July 2009

Fluoxetina Bexal




Fluoxetina Bexal may be available in the countries listed below.


Ingredient matches for Fluoxetina Bexal



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetina Bexal in the following countries:


  • Spain

International Drug Name Search

Tenasil




Tenasil may be available in the countries listed below.


Ingredient matches for Tenasil



Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Tenasil in the following countries:


  • Poland

International Drug Name Search

Lanzogastro




Lanzogastro may be available in the countries listed below.


Ingredient matches for Lanzogastro



Lansoprazole

Lansoprazole is reported as an ingredient of Lanzogastro in the following countries:


  • Portugal

International Drug Name Search

Theotard




Theotard may be available in the countries listed below.


Ingredient matches for Theotard



Theophylline

Theophylline is reported as an ingredient of Theotard in the following countries:


  • Israel

International Drug Name Search

Wednesday, 22 July 2009

Arthri Dog




Arthri Dog may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Arthri Dog



Phenylbutazone

Phenylbutazone calcium salt (a derivative of Phenylbutazone) is reported as an ingredient of Arthri Dog in the following countries:


  • France

Prednisolone

Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Arthri Dog in the following countries:


  • France

International Drug Name Search

Tuesday, 21 July 2009

Paralen




Paralen may be available in the countries listed below.


Ingredient matches for Paralen



Paracetamol

Paracetamol is reported as an ingredient of Paralen in the following countries:


  • Czech Republic

  • Slovakia

International Drug Name Search

Thursday, 16 July 2009

MetroGel




In the US, MetroGel (metronidazole topical) is a member of the drug class topical acne agents and is used to treat Perioral Dermatitis and Rosacea.

US matches:

  • MetroGel Cream

  • MetroGel Gel

  • MetroGel Vaginal Gel

  • MetroGel

  • MetroGel-Vaginal

  • Metrogel Topical

  • MetroGel Vaginal

UK matches:

  • Metrogel
  • Metrogel (SPC)

Ingredient matches for MetroGel



Metronidazole

Metronidazole is reported as an ingredient of MetroGel in the following countries:


  • Canada

  • Chile

  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Germany

  • Honduras

  • Luxembourg

  • Mexico

  • Nicaragua

  • Panama

  • Taiwan

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.